Deficits Could Be Next 'Black Swan'
Rich Vs. Poor IT Organizations
UK Trade & Investment is organising a five-day camp for UK based medical-technology based companies which can address the needs of India market
Synthetic biology is set to play a crucial role in business
Edward J. Ludwig speaks to BW’s Noemie Bisserbe about Becton, Dickinson and Company's strategy and plans for India
At Geisinger, all parties -- patients, physicians, nurses, administrators, and the internal insurance plan -- have timely access to each patient's medical history
The promise of tailoring medicine to a person's genetic makeup is poised to bear fruit in a major way in the next few years
Lobbying for and against the GM food peaks in the run up to the final clearance
Human Genome Sciences Inc said its experimental lupus drug Benlysta was successful in a second large clinical trial, paving the way for approval
India has declared itself free from Bird Flu, or the Avian Influenza (H5N1), and has notified the same to the World Organisation for Animal Health
GlaxoSmithKline won a further 22 orders for its H1N1 swine flu vaccine in the last two months, taking the total number of doses ordered to some $3.5 billion
India can learn from the US’s mistakes in health insurance
Nova Medical Centers has joined hands with New Yorkbased Ranawat Orthopaedics
A not-for-profit project takes on diabetes in rural Tamil Nadu
Insurance options could change the dynamics of stem cell banking
Laughter may be an adjunct medicine for patients with diabetes
Novartis said its trial with 100 volunteers showed a potentially protective immune response in 80 per cent of subjects after one dose
They have the money, the metier, and the mission. Can these focused healthcare providers deliver
